Benzinga
Benzinga
Benzinga
mercoledì, settembre 30

VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc.

VRPXOTCEM
Trade with Public
Trade with Public
$0.6695
-0.55-45.12%
In chiusura: Apr 2, 5:00 PM EST
$0.2460
-0.97-79.84%
Pre-mercato: Jul 18, 3:00 AM EST
PanoramicaNotiziePrevisioni utiliObiettivi di prezzoDati finanziariSentimentAzionariatoConfronta

VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc. (VRPX).

Price Target Range —

Analyst Consensus — 1 Analysts

1Hold
# Analysts1

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Oct 9, 2024Maxim GroupNaz RahmanDowngradeBuy→Hold—
Jul 19, 2024Maxim GroupNaz RahmanUpgradeHold→Buy$3
More with Benzinga EdgeGet Access

Analyst Ratings News

US Stocks Likely To Open Higher Following A Sell-Off, 'This Choppy Start To 2025 Isn't Abnormal. Don't Panic,' Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections

U.S. stock futures rose on Friday following Thursday's sell-off. Futures advanced except the small-cap gauge Russell 2000.
Rishabh Mishra

This FactSet Research Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday

Avi Kapoor

PRO
Maxim Group Downgrades Virpax Pharmaceuticals to Hold

Maxim Group analyst Naz Rahman downgrades Virpax Pharmaceuticals (NASDAQ:VRPX) from Buy to Hold.
Benzinga Newsdesk

PRO
Maxim Group Upgrades Virpax Pharmaceuticals to Buy, Announces $3 Price Target

Maxim Group analyst Naz Rahman upgrades Virpax Pharmaceuticals (NASDAQ:VRPX) from Hold to Buy and announces $3 price target.
Benzinga Newsdesk

PRO
Maxim Group Downgrades Virpax Pharmaceuticals to Hold

Maxim Group analyst Naz Rahman downgrades Virpax Pharmaceuticals (NASDAQ:VRPX) from Buy to Hold.
Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022

Upgrades
Benzinga Insights

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved